StonvexLoading…
StonvexStonvexStonvexCore line items from MASI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-03 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.53B | $1.40B | $1.28B | $2.04B |
Operating Income | $310.00M | $63.00M | $166.00M | $210.00M |
Net Income | $-151.50M | $-304.90M | $81.50M | $143.50M |
EPS (Diluted) | $-2.80 | $-5.60 | $1.51 | $2.60 |
Total Assets | $1.70B | $2.63B | $3.04B | $3.21B |
Total Liabilities | $977.70M | $1.57B | $1.68B | $1.87B |
Cash & Equivalents | $152.30M | $123.60M | $163.00M | $202.90M |
Free Cash Flow OCF − CapEx | $198.40M | $175.30M | $55.70M | $-23.40M |
Shares Outstanding | 52.10M | 53.60M | 52.80M | 52.50M |